ACR Seeks Member Input on FDA GenAI Discussion Paper
The FDA published a discussion paper Aug. 18, asking stakeholders for feedback about agency oversight of generative AI-enabled medical devices. Public comments on the paper will inform future related FDA regulatory policy initiatives.
Read more